• Nutrition Research and Practice
• /
• 제2권4호
• /
• pp.240-246
• /
• 2008

Cassia tora L. seeds have previously been reported to reduce blood glucose level in human and animals with diabetes. In the present study, the effects of Cassia tora L. seed butanol fraction (CATO) were studied on postprandial glucose control and insulin secretion from the pancreas of the normal and diabetic rats. Diabetes was induced by an i.p. injection of Streptozotocin (55 mg/kg BW) into the male Sprague-Dawley rats. The postprandial glucose control was monitored during a 240 min-period using a maltose loading test. In normal rats, rats fed CATO (20 mg/l00 g BW/d) showed lower postprandial glucose levels in all the levels from 30 min up to 180 min than those in the control rats without CATO (p<0.05). In diabetic rats, those levels in the CATO group seemed to be lower during the $30{\sim}180$ min, but only glucose level at 30 min showed significant difference compared to that in the control group. Moreover, CATO delayed the peak time of the glucose rise in both normal and diabetic rats in the glucose curves. On the other hand, when CATO was administered orally to the diabetic rats for 5 days, 12 hr fasting serum glucose level was decreased in the diabetic rats (p<0.05). Degree of a decrease in 12 hr fasting serum insulin levels was significantly less in the diabetic CATO rats as compared to diabetic control rats. On the last day of feeding, P cells of the pancreas were stimulated by 200 mg/dL glucose through a 40 min-pancreas perfusion. Amounts of the insulin secreted from the pancreas during the first phase ($11{\sim}20$ min) and the second phase ($21{\sim}40$ min) in the CATO fed diabetic rats were significantly greater than those in the diabetic control group (p<0.05). These findings indicated that constituents of Cassia tora L. seeds have beneficial effect on postprandial blood glucose control which may be partially mediated by stimulated insulin secretion from the pancreas of the diabetic rats.

• Journal of Korean Biological Nursing Science
• /
• 제25권2호
• /
• pp.131-142
• /
• 2023

Purpose: The aim of this study was to assess lipid levels and to identify groups with poor lipid control group among patients with dyslipidemia. Methods: Data from 1,399 Korean patients with dyslipidemia older than 20 years were extracted from the Korea National Health and Nutrition Examination Survey. Complex sample analysis and decision-tree analysis were conducted with using SPSS for Windows version 27.0. Results: The mean levels of total cholesterol (TC), triglyceride (TG), low density lipoprotein-cholesterol (LDL-C), and high density lipoprotein cholesterol were 211.38±1.15 mg/dL, 306.61±1.15 mg/dL, 118.48±1.08 mg/dL, and 42.39±1.15 mg/dL, respectively. About 61% of participants showed abnormal lipid control. Poor glycemic control groups (TC ≥ 200 mg/dL or TG ≥ 150 mg/dL or LDL-C ≥ 130 mg/dL) were identified through seven different pathways via decision-tree analysis. Poor lipid control groups were categorized based on patients' characteristics such as gender, age, education, dyslipidemia medication adherence, perception of dyslipidemia, diagnosis of myocardial infarction or angina, diabetes mellitus, perceived health status, relative hand grip strength, hemoglobin A1c, aerobic exercise per week, and walking days per week. Dyslipidemia medication adherence was the most significant predictor of poor lipid control. Conclusion: The findings demonstrated characteristics that are predictive of poor lipid control and can be used to detect poor lipid control in patients with dyslipidemia.

• Investigative and Clinical Urology
• /
• 제59권6호
• /
• pp.399-409
• /
• 2018

Purpose: To analyze data from an observational, prospective, cumulative registry study in 805 hypogonadal men stratified by mild or moderate-to-severe lower urinary tract symptoms (LUTS) according to International Prostate Symptom Score. Materials and Methods: A total of 412 men underwent testosterone therapy (TTh) with injectable testosterone undecanoate, 393 men served as untreated controls. Measures of urinary function, anthropometric and metabolic parameters were performed at least twice per year. Results: Data from 615 men with mild LUTS (253 treated, 362 untreated) and 190 with moderate-to-severe LUTS (159 treated, 31 untreated) were available. During a follow-up period of 8 years a significant improvement of LUTS was noted for all TTh-patients whereas the control-groups showed deterioration or fluctuation around initial values. Despite advancing age, TTh fully prevented worsening of symptoms. In parallel, a considerable improvement of anthropometric parameters, lipids and glycemic control, blood pressure, C-reactive protein, and quality of life was found. Moderate-to-severe LUTS was associated with worse cardiometabolic risk profile at baseline as well as worse cardiovascular outcomes during follow-up in comparison to mild LUTS. Effect size of TTh was more pronounced in men with moderate-to-severe than with mild LUTS. Conclusions: Correcting hypogonadism by TTh is highly effective and safe for improving LUTS in hypogonadal men. TTh may also improve cardiometabolic risk and major adverse cardiovascular events.

• Laboraroty Animal Research
• /
• 제34권4호
• /
• pp.140-146
• /
• 2018

Though bile acids have been well known as digestive juice, recent studies have demonstrated that bile acids bind to their endogenous receptors, including Farnesoid X receptor (FXR) and G protein-coupled bile acid receptor 1 (GPBAR1; TGR5) and serve as hormone to control various biological processes, including cholesterol/bile acid metabolism, glucose/lipid metabolism, immune responses, and energy metabolism. Deficiency of those bile acid receptors has been reported to induce diverse metabolic syndromes such as obesity, hyperlipidemia, hyperglycemia, and insulin resistance. As consistent, numerous studies have reported alteration of bile acid signaling pathways in type II diabetes patients. Interestingly, bile acids have shown to activate TGR5 in intestinal L cells and enhance secretion of glucagon-like peptide 1 (GLP-1) to potentiate insulin secretion in response to glucose. Moreover, FXR has been shown to crosstalk with TGR5 to control GLP-1 secretion. Altogether, bile acid receptors, FXR and TGR5 are potent therapeutic targets for the treatment of metabolic diseases, including type II diabetes.

• Journal of Korean Biological Nursing Science
• /
• 제23권3호
• /
• pp.170-179
• /
• 2021

Purpose: The aim of this study was to identify core keywords and topic groups in the 'Diabetes mellitus and mobile applications' field of research for better understanding research trends in the past 20 years. Methods: This study was a text-mining and topic modeling study including four steps such as 'collecting abstracts', 'extracting and cleaning semantic morphemes', 'building a co-occurrence matrix', and 'analyzing network features and clustering topic groups'. Results: A total of 789 papers published between 2002 and 2021 were found in databases (Springer). Among them, 435 words were extracted from 118 articles selected according to the conditions: 'analyzed by text network analysis and topic modeling'. The core keywords were 'self-management', 'intervention', 'health', 'support', 'technique' and 'system'. Through the topic modeling analysis, four themes were derived: 'intervention', 'blood glucose level control', 'self-management' and 'mobile health'. The main topic of this study was 'self-management'. Conclusion: While more recent work has investigated mobile applications, the highest feature was related to self-management in the diabetes care and prevention. Nursing interventions utilizing mobile application are expected to not only effective and powerful glycemic control and self-management tools, but can be also used for patient-driven lifestyle modification.

• Nutrition Research and Practice
• /
• 제17권4호
• /
• pp.698-716
• /
• 2023

BACKGROUND/OBJECTIVES: The aim of this study was to evaluate the sensory properties of antioxidant-rich bread made by adding pomegranate peels and their effects on anthropometric measurements and metabolic and oxidative parameters of individuals with type 2 diabetes after consumption. SUBJECTS/METHODS: This randomized, double-blind, placebo-controlled study was conducted with 22 individuals aged between 19 and 64 years who had been diagnosed with type 2 diabetes for at least 5 years, used only metformin, did not lose more than 10% of their body weight in the last 6 months, and had a body mass index of ≥ 25.0 kg/m². While the study group (n = 11) consumed bread containing 500 mg pomegranate peel daily for 8 wk, the control group (n = 11) consumed standard bread. Anthropometric measurements and metabolic and oxidative parameters of individuals were evaluated at the beginning and end of the study. RESULTS: Decreases were detected in the waist circumference, waist/hip and waist/height ratios, body fat percentages, blood pressure, and serum insulin, triglyceride, and total cholesterol levels in the individuals in the treatment group, compared with those in the control group (P < 0.05). CONCLUSIONS: Pomegranate peel consumption by individuals with type 2 diabetes may have positive effects on anthropometric measurements and glycemic and lipid parameters.

• Clinical and Experimental Pediatrics
• /
• 제50권6호
• /
• pp.565-569
• /
• 2007

목 적 : 란투스는 최대효과 없이, 24시간 동안 효과가 지속되기 때문에 NPH에 비해 생리적인 기저 인슐린 대체 제제이다. 1형 당뇨병 소아 및 청소년에서 란투스와 휴마로그의 병합 치료와 혼합형 인슐린의 혈당 조절 효과를 비교하기 위해 본 연구를 시행 하였다. 방 법 : 혼합형 인슐린에서 란투스와 휴마로그의 병합 치료로 인슐린 요법을 바꾼 1형 당뇨병을 가진 20세 미만의 환아 25명을 대상으로 란투스 시작 전과 시작 6개월 후의 하루 인슐린 투여량, 월간 저혈당 횟수, 공복시 혈당, C-peptide 농도 및 당화혈색소를 비교하였다. 이들 중 11명의 환아와 혼합형 인슐린을 사용하는 10명의 환아를 대상으로 24시간 자가 혈당 검사를 시행하여 매 식사 30분 전과 식후 30분 간격으로 2시간 동안의 혈당과 취침 전의 혈당 비교하였다. 결 과 : 란투스 치료 6개월 후 저혈당 빈도가 월간 15.1회에서 7.6회로 50% 감소하였으며, 특히 야간 저혈당 빈도는 월간 6.7회에서 2.5회로 67% 감소하였다. 당화혈색소는 란투스 치료 6개월 후 9.3%에서 8.7%로 감소하였다. 24시간 혈당 검사에서는 란투스를 사용하는 군에서 아침 식후 30분, 60분, 90분, 120분에서의 혈당이 혼합형 인슐린을 사용하는 군보다 유의하게 낮았고, 24시간 평균 혈당은 란투스 사용군이 $164.1{\pm}78.2mg/dL$로 혼합형 인슐린 사용군의 $211.5{\pm}108.7mg/dL$보다 유의하게 낮았다. 결 론 : 1형 당뇨병 소아 및 청소년에서 란투스와 휴마로그의 병합 치료는 혼합형 인슐린과 비교하여 혈당 조절에 보다 효과적이고, 특히 야간 저혈당 감소에 유효한 것으로 생각된다.

• 한국산학기술학회논문지
• /
• 제11권4호
• /
• pp.1520-1527
• /
• 2010

본 연구는 국민건강보험공단의 당뇨병 사례관리 프로그램 참여자들을 대상으로 사례관리 프로그램의 중재 효과 및 효과의 지속성을 확인하고자 하였다. 기간은 2007년 5월 1일부터 2007년 6월 30일까지 국민건강보험공단의 당뇨병 사례관리 프로그램 참여자 115명(남성 51명, 여성 64명)을 조사대상으로 하였다. 조사대상은 사례관리 1회 실시군(Group I)과 사례관리 2회 실시군(Group I)으로 구분하여 사례관리 실시 직전, 실시 직후, 6개월 및 12개월 후의 사례관리 프로그램의 중재효과 및 효과의 지속성을 평가하였다. 연구결과 당뇨병 사례관리 프로그램 참여자들의 혈당치는 사례관리 실시 직전에 비해 실시 직후에 유의하게 개선되었으나, 6개월과 12개월 후에는 다시 증가하는 경향을 보였다. 또한 사례관리 1회 실시군(Group I)에 비해 사례관리 2회 실시군(Group II)에서 사례관리 프로그램의 중재 효과가 지속됨을 확인할 수 있었다.

• 한국임상약학회지
• /
• 제27권2호
• /
• pp.99-104
• /
• 2017

Objectives: This study aimed to compare effects on glycemic control and weight loss between the metformin/dapagliflozin combination and the metformin/sitagliptin combination in type 2 diabetic patients. Methods: This study retrospectively reviewed the medical records, from January $1^{st}$ 2015 to March $31^{st}$ 2016, of type 2 diabetic patients who were older than 18 and were prescribed with dapagliflozin or sitagliptin in combination with metformin. Hemoglobin $A_{1c}$ ($HbA_{1c}$) levels and weights were measured every 3 months. Results: The dapagliflozin group showed a greater decrease in $HbA_{1c}$ levels after 3 months (-0.75% vs. 0.01%, P<0.001), 6 months (-0.36% vs. 0.08%, P=0.029), and 9 months (-0.53% vs. 0.08%, P=0.046) compared to the sitagliptin group. Also, the dapagliflozin group showed a greater significant decrease in the rate of change in $HbA_{1c}$ levels after 3 months (-0.09 vs. 0.01, P<0.001), 6 months (-0.04 vs. 0.01, P=0.031), 9 months (-0.07 vs. 0.02, P=0.029), and 12 months (-0.05 vs. 0.05, P=0.047). Furthermore, the dapagliflozin group showed a greater decrease in amount of weight change after 3 months (-2.46 kg vs. 0.37 kg, P<0.001), 6 months (-3.02 kg vs. 0.13 kg, P<0.001), and 9 months (-2.27 kg vs. 0.50 kg, P=0.002). Finally, the dapagliflozin group showed a greater decrease in the rate of change in weight after 3 months (-3.10% vs. 0.52%, P<0.001), 6 months (-3.83% vs. 0.21%, P<0.001), 9 months (-2.84% vs. 0.79%, P=0.002), and 12 months (-4.91% vs. 0.44%, P<0.001). Conclusions: It was concluded that dapagliflozin is more effective than sitagliptin for type 2 diabetic patients.

• 산업융합연구
• /
• 제22권2호
• /
• pp.143-151
• /
• 2024

본 연구는 한국 30세 이상 60미만 성인을 대상으로 당화혈색소 6.5% 이상 그룹과 미만 그룹간의 일반적 특성, 신체적 요인, 정신적 요인, 건강문해력 특성 등의 차이를 비교하고, 혈당조절에 영향을 미치는 요인을 성별에 따라 비교하기 위해 시행하였다. 2019년도부터 2021년도까지 국민건강영양조사 원시자료를 이용히여 층화집락추출 및 가중치를 반영하여 복합표본분석 방법을 적용하였다. 한국 30세 이상 60세미만 성인을 대상으로 당화혈색소 6.5% 이상 그룹과 미만 그룹의 인구사회학적 특성, 신체적 요인, 정신적 요인, 건강문해력 등에 따른 차이는 Rao-Scott χ² test로 분석하였고, 성별에 따른 영향요인을 확인하기 위해 로지스틱 회귀분석 방법으로 분석하였다. 본 연구의 대상자는 438명 이었으며 당화혈색소 6.5% 이상 그룹은 348명으로 나타났다. 당화혈색소 6.5% 미만 그룹과 이상 그룹 간 유의한 차이가 있는 요인은 성별(RCχ²: 7.9, p=.012), 비만(RCχ²: 13.1, p=.006), 당뇨병 유병기간(RCχ²: 9.55, p=.029)이었다. 건강 전문가는 성별, 비만, 당뇨병 유병기간 등이 고혈당 위험성을 높이는 요인임을 파악하고, 혈당 조절 개선을 위한 중재 적용 시 대상자의 신체적 요인, 건강문해력 등을 고려한 건강 증진 전략을 제시할 필요가 있다.